Welcome to LookChem.com Sign In|Join Free
  • or
PLX647 is a dual inhibitor of the receptor tyrosine kinases FMS and KIT, selectively targeting these proteins with high specificity and potency. It demonstrates inhibitory effects on the proliferation of cells expressing constitutively active FMS or KIT, as well as ligand-dependent growth of cells with endogenous FMS and KIT. Additionally, PLX647 has been shown to inhibit differentiation of human osteoclast precursor cells and reduce inflammation and bone destruction in various animal models.

873786-09-5

Post Buying Request

873786-09-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

873786-09-5 Usage

Uses

Used in Oncology:
PLX647 is used as a tyrosine kinase inhibitor for targeting c-Kit and c-Fms in cancer treatment. Its selectivity for these kinases makes it a promising candidate for the treatment of malignancies driven by the dysregulation of FMS and KIT, potentially leading to the inhibition of tumor growth and progression.
Used in Inflammatory Conditions:
PLX647 is used as an anti-inflammatory agent for reducing the release of pro-inflammatory cytokines such as TNF-α and IL-6 in animal models of inflammation. This application may be beneficial in treating conditions characterized by excessive inflammation, such as autoimmune diseases.
Used in Allergy and Immune Responses:
PLX647 is used as a therapeutic agent for inhibiting mast cell degranulation in mouse models of passive cutaneous anaphylaxis (PCA). This suggests its potential use in treating allergic reactions and modulating immune responses.
Used in Bone Diseases:
PLX647 is used as a bone protective agent for inhibiting bone destruction and delaying disease progression in mouse models of collagen-induced arthritis (CIA). It also reverses bone osteolysis and allodynia in a syngeneic rat model of cancer-induced bone pain, indicating its potential use in treating bone-related diseases and conditions associated with pain and bone loss.

references

[1]. zhang c, ibrahim pn, zhang j, et al. design and pharmacology of a highly specific dual fms and kit kinase inhibitor. proc natl acad sci u s a, 2013, 110(14): 5689-5694.

Check Digit Verification of cas no

The CAS Registry Mumber 873786-09-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,3,7,8 and 6 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 873786-09:
(8*8)+(7*7)+(6*3)+(5*7)+(4*8)+(3*6)+(2*0)+(1*9)=225
225 % 10 = 5
So 873786-09-5 is a valid CAS Registry Number.

873786-09-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma

  • (SML0966)  PLX647  ≥98% (HPLC)

  • 873786-09-5

  • SML0966-5MG

  • 1,113.84CNY

  • Detail
  • Sigma

  • (SML0966)  PLX647  ≥98% (HPLC)

  • 873786-09-5

  • SML0966-25MG

  • 4,493.97CNY

  • Detail

873786-09-5Downstream Products

873786-09-5Relevant academic research and scientific papers

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 873786-09-5